InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Dietz Thomas John, 董事. Director active across 3 companies, notably Paratek Pharmaceuticals, Inc.. Cumulatively, 9 filings have been published. Split: 1 buy · 2 sells. Total volume traded: €120k. Activity tracked since 16 February 2022. The latest transaction was filed on 26 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Dietz Thomas John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
20,000 股@ US$1.720.019% mcap51.6% 占其流量Common StockSEC:0001104659-26-102467:0
104,500 股Common StockSEC:0001104659-26-029646:0
83,000 股Common StockSEC:0001104659-25-125256:0
49,250 股Common StockSEC:0000899243-23-019349:0
20,000 股0Common StockSEC:0000904454-23-000101:0
50,000 股@ US$1.431672.7% 占其流量Common StockSEC:0001567619-23-001284:0
标准退出：2023年4月23日 (T+90)
22,500 股@ US$1.16927.3% 占其流量Common StockSEC:0001140361-22-047071:0
6,000 股0Common StockSEC:0001140361-22-009257:0
20,000 股0Common StockSEC:0000904454-22-000163:0
9 条申报中的 9 条
About Dietz Thomas John
Dietz Thomas John is Administrateur and has filed 8 disclosures in total. Across the 8 recent filings we hold, the period runs from 2022-02-18 to 2026-03-17, with EUR 65881 of buys and EUR 24790 of sells, mainly at Eiger BioPharmaceuticals, Inc., as well as filings at Paratek Pharmaceuticals, Inc. and CYPHERPUNK TECHNOLOGIES INC.
